Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
Cancer Biol Med
.
2022 Aug 30;19(8):1117-1120.
doi: 10.20892/j.issn.2095-3941.2022.0403.
Authors
Qiu Minghan
1
2
,
Wu Shan
1
2
,
Chen Xinrui
1
2
,
Wang Huaqing
1
2
Affiliations
1
Department of Oncology, Tianjin Union Medical Center, Nankai University, Tianjin 300191, China.
2
The Institute of Translational Medicine, Tianjin Union Medical Center, Nankai University, Tianjin 300121, China.
PMID:
36069539
PMCID:
PMC9425190
DOI:
10.20892/j.issn.2095-3941.2022.0403
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Lymphoma, Large B-Cell, Diffuse* / drug therapy
Medical Oncology